-
Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided t...
Study Step 2: Characteristics of 163 patients. -
Summary of biomarker testing frequency and mutation prevalence by country.
Summary of biomarker testing frequency and mutation prevalence by country. -
Costs, effectiveness, and ICER of the 379 patients before propensity score ma...
Costs, effectiveness, and ICER of the 379 patients before propensity score matching. -
r37980778c78--90671216a4c02dedf2e50f60d0d8f898
Characteristics of the included studies for the overall survival (OS) analysis. -
Costs, effectiveness, and ICER of the 192 propensity score-matched patients.
Costs, effectiveness, and ICER of the 192 propensity score-matched patients. -
r37980778c78--f1fea14605976beaf0e9965d36350a66
ADC Histogram Parameters of High- and Low-Grade of NSCLC. -
r37980778c78--718b022ea5411d7e7a2eadd21d07e7eb
Demographic and clinical characteristics of patients by receipt of one or more molecular testsa (yes/no) in Italy, Spain, Germany, and Australia. -
Molecular test-related characteristics—at the test level—for nonsquamous aNSC...
Molecular test-related characteristics—at the test level—for nonsquamous aNSCLC in each country. -
Clinical characteristics of the 192 propensity score-matched patients and tho...
Clinical characteristics of the 192 propensity score-matched patients and those excluded after matching. -
Treatment patterns by predictive biomarker testing (<i>EGFR</i> mutation and ...
Treatment patterns by predictive biomarker testing (EGFR mutation and ALK rearrangement) and mutation status for patients with nonsquamous NSCLC in Japan, Korea, Taiwan, and... -
r37980778c78--b3b29b805cd2d8c22411a000e90498f2
Summary of survival outcomes by definition of survival time. -
The D-dimer level predicts the postoperative prognosis in patients with non-s...
BackgroundCarcinoma cells often modulate coagulation and fibrinolysis among cancer patients. Plasma dimerized plasmin fragment D (D-dimer) has been reported as a prognostic... -
Characteristics of patients.
Pneumonia was defined as evidence of clinical signs and symptoms of pneumonia and evidence of infiltrate in CTPA that was not attributable to pulmonary infarction due to PE, and... -
Pathological and treatment parameters of both groups.
Pathological and treatment parameters of both groups. -
r37980778c78--e21fbb1a5697fb48bb351773e74d2ecf
ADC Histogram Parameters of Lymphovascular Invasion and Pleural Invasion of NSCLC. -
Characteristics of the included studies for the disease-free survival (DFS) a...
Characteristics of the included studies for the disease-free survival (DFS) analysis.
